MCI-BCM Sponsored Target Screening Funding Announcement

About this program

The Male Contraceptive Initiative (MCI) and Baylor College of Medicine (BCM) jointly sponsor this opportunity to screen validated male contraceptive targets for small-molecule inhibitors using DNA-Encoded Chemistry Technology (DEC-Tec). The program aims to identify potential 'hit' molecules for the development of new male contraceptives, with successful projects potentially leading to further collaboration with BCM.

Eligible applicants include academic institutions, for-profit organizations, and other entities, both foreign and domestic, with current MCI grantees also eligible to apply. However, duplicate or highly overlapping grant awards from other funding agencies are not accepted, and there are no direct funds associated with this award.